A Phase 2 interventional study of BPR-101 capsules:Investigational product for the treatment of BV and Placebo:matching the investigational product in appearance, dosage form, and route of administration in Bacterial Vaginosis, sponsored by Chengdu Syncor Pharmaceutical Co., Ltd.. Not yet recruiting at 1 site in China. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by Chengdu Syncor Pharmaceutical Co., Ltd. · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Vaginosis, Bacterial with a site in China — 6 open to participants now, 6 under way, none of them phase 3. Vaginosis, Bacterial · China.
Among the 16 studies in Vaginosis, Bacterial with a site in China, this one is the 10th largest by planned enrollment, is one of 3 that started in 2026, is one of 4 in phase 2, and was the 14th registered.
240 studies on the registry are indexed under Vaginosis, Bacterial; 39 are open to participants now.
Browse Vaginosis, Bacterial studies →6 of the 16 studies in Vaginosis, Bacterial with a site in China are open now. Recruiting first, the newest first:
Changchun GeneScience Pharmaceutical Co., Ltd. · Sites in China
Ages 18–50 · Women only
Zhujiang Hospital · Sites in China
Ages 18–55 · Women only
Peking University Shenzhen Hospital · Sites in China
Ages 18–55 · Women only · Healthy volunteers
SPH Sine Pharmaceutical Laboratories Co., Ltd. · Sites in China
Ages 18–55 · Women only
Changchun GeneScience Pharmaceutical Co., Ltd. · Sites in China
Ages 18–55 · Women only · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 23 Vaginosis, Bacterial studies recruiting now, 7 (30%) set no upper age limit and 16 (70%) stop at 75 or younger; 2 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 50 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 80 is below the median of 100 across 203 interventional studies indexed under Vaginosis, Bacterial.
Median enrollment 123 across the 16 interventional studies. Of the 7 that completed or were terminated, 2 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 16 have an industry lead sponsor. The 10 most frequent:
Chengdu Syncor Pharmaceutical Co., Ltd. is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Chengdu Syncor Pharmaceutical Co., Ltd. has 1 study filed under Vaginosis, Bacterial — fewer than ten, so there is no comparison to draw.
4 of the studies in Vaginosis, Bacterial with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04771728Peking University Shenzhen HospitalA Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis | 2026-12-01 |
| NCT07663838Changchun GeneScience Pharmaceutical Co., Ltd.A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV) | 2027-01-05 |
| NCT07483671Chengdu Syncor Pharmaceutical Co., Ltd.Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients | 2027-01-24 |
| NCT07888699SPH Sine Pharmaceutical Laboratories Co., Ltd.WST03 Capsule Combined With Metronidazole for Bacterial Vaginosis | 2027-10-15 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Vaginosis, Bacterial with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This trial employed a multicenter, randomized, double-blind, parallel, placebo-controlled design to evaluate the preventive effect of BPR-101 capsules combined with metronidazole on the recurrence of BV, as well as the cure rate and safety.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
The top of the normal range for a blood test, as set by the laboratory that runs it. Each lab prints its own range next to your result.
“≤ 2.5 × ULN” means the result can be up to two and a half times that top value.
Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.
Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
The other ingredients in a medicine besides the active drug, such as fillers, colors or preservatives.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ULN (upper limit of normal)
The top of the normal range for a blood test, as set by the laboratory that runs it. Each lab prints its own range next to your result.
“≤ 2.5 × ULN” means the result can be up to two and a half times that top value.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ALT and AST (liver enzymes)
Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.
Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Excipients
The other ingredients in a medicine besides the active drug, such as fillers, colors or preservatives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Capsules: Insert the capsule deep into the vagina. Metronidazole: Oral administration.
Drug: BPR-101 capsules:Investigational product for the treatment of BV
Capsules: Insert the capsule deep into the vagina. Metronidazole: Oral administration.
Other: Placebo:matching the investigational product in appearance, dosage form, and route of administration
administered vaginally and orally as per study protocol.
administered vaginally and orally as per study protocol.
The recurrence rate of BV
Nugent score + Amsel's test; any positive result indicates a relapse
Time frame: Day 90
The recurrence rate of BV
Time frame: Day 25 and 60
The cure rate of BV
Time frame: Day 15
The recurrence rate of BV in cured patients
Time frame: Day 90
The time from the last dose of trial medication to the first recurrence of BV
Time frame: From the last dose of medication in the trial to the first recurrence of BV
Adverse events and serious adverse events, vital sign measurements, physical examination, gynecological examination, and laboratory test results (including blood/urine pregnancy test, complete blood count, blood biochemistry, and urinalysis).
Time frame: Throughout the research period
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Jan 2027, 9 months later.
Of 14 phase 2 interventional studies under Vaginosis, Bacterial, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 41. This study's planned 9 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chengdu Syncor Pharmaceutical Co., Ltd.